Pet Drug Reports

Afoxolaner + Milbemycin Oximeadverse event reports that FDA received

Combination of 2 active ingredients

The Green Book lists no brand name for exactly these active ingredients.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Read this first. FDA says this about the data:

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .

This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.

Contacting a veterinarianHow to report to FDA

From July 2016 to November 2025, FDA received 36 adverse event reports that name a drug with afoxolaner and milbemycin oxime as its active ingredients. Of the 36 reports, 35 (97.2%) are about dogs.

In January to March 2026, FDA received no reports that name this drug. The signs that appear in the largest number of the 36 reports are "Lack of efficacy (endoparasite) - heartworm" and "Vomiting". A report is not proof that a drug caused a sign.

Fewer than 20 reports named this drug in the 12 months before June 2026, so this page gives no change. Reports about dogs are 97.2% of the reports that name this drug, and 72.6% of all reports.

Search engines list a drug page with 500 reports or more in all years. The page also needs 30 reports or more in the 12 months to June 2026. This page is under one of these numbers. The site keeps the page and keeps it out of search engines.

Since the last update of the FDA data

The latest update of the FDA data, recorded on , changed no count of this page.

January to March 2026 is the latest closed quarter in the data. In that quarter FDA received 0 reports that name afoxolaner + milbemycin oxime: 0 dog, 0 cat, 0 horse, 0 other or not given.

All updatesFeed of updates (RSS)

Signs that the reports list

A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 36 reports that list the sign. One report can list more than one sign.

The sign that is in the largest number of the reports comes first.

  1. Lack of efficacy (endoparasite) - heartworm[the product did not have the expected effect: heartworm]47.2%17 reports
  2. Vomiting13.9%5 reports
  3. Lethargy[unusually tired or inactive]11.1%4 reports
  4. Seizure NOS[seizure, type not specified]11.1%4 reports
  5. Abnormal ultrasound finding8.3%3 reports
  6. Diarrhoea[diarrhea]8.3%3 reports
  7. Behavioural disorder NOS[behaviour change, type not specified]5.6%2 reports
  8. Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]5.6%2 reports
  9. Elevated serum alkaline phosphatase (ALP)[a liver and bone enzyme above the normal range]5.6%2 reports
  10. Lack of efficacy (bacteria) - Borrelia[the product did not have the expected effect: Borrelia (Lyme disease bacteria)]5.6%2 reports
  11. Other abnormal test result NOS[abnormal laboratory result, type not specified]5.6%2 reports
  12. Abdominal discomfort2.8%1 reports
  13. Abnormal cytology2.8%1 reports
  14. Aggression2.8%1 reports
Show the next 16 signs
  1. Agitation2.8%1 reports
  2. Allergy NOS[NOS: not otherwise specified]2.8%1 reports
  3. Anxiety2.8%1 reports
  4. Ataxia[unsteady, uncoordinated movement]2.8%1 reports
  5. Balance problem2.8%1 reports
  6. Bloody diarrhoea[diarrhea with blood]2.8%1 reports
  7. Bruising2.8%1 reports
  8. Claw / hoof / nail loss2.8%1 reports
  9. Conjunctival oedema2.8%1 reports
  10. Constipation2.8%1 reports
  11. Corneal disorder NOS[NOS: not otherwise specified]2.8%1 reports
  12. Corneal oedema2.8%1 reports
  13. Corneal ulcer2.8%1 reports
  14. Cough2.8%1 reports
  15. Death2.8%1 reports
  16. Decreased appetite2.8%1 reports

The list shows 30 of 95 coded signs. A report is not proof that a drug caused a sign. Download all signs (CSV)

Reports by species

The share is of all 36 reports that name afoxolaner + milbemycin oxime. The other reports give a different species or no species.

Reports for each month, Jul 2021 to Jun 2026

Dog19 reports

No chart: no month has 5 or more reports.

Cat0 reports

No chart: no month has 5 or more reports.

Horse0 reports

No chart: no month has 5 or more reports.

Other or not given1 report

No chart: no month has 5 or more reports.

The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

Reports by year

  • Dog
  • Cat
  • Horse
  • Other or not given
Reports that name afoxolaner + milbemycin oxime, by the year in which FDA received them and by species
YearDogCatHorseOther or not givenAll species
202580008
202440004
202330003
202220013
202190009
202050005
201930003
201610001

2025 has the reports that FDA received through Nov 2025. Download the years (CSV)

What the reports record

Outcome at the time of the report

  • Recovered/Normal13.9%5
  • Recovered with Sequela[recovered, with a lasting effect]5.6%2
  • Ongoing22.2%8
  • Died2.8%1
  • Euthanized0%0
  • Outcome Unknown52.8%19

An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 36 reports that name afoxolaner + milbemycin oxime.

A report about more than one animal can have more than one outcome.

Kind of report

  • Safety issue47.2%17
  • Lack of expected effectiveness44.4%16
  • Both safety and lack of expected effectiveness5.6%2
  • Manufacturing or product defect0%0
  • Other2.8%1

32 reports say if the event was serious. 15.6% of them have the serious flag. The person who sends the report sets the flag.

Show age, weight, breed and route

Age of the animal

  • Under 1 year13.9%5
  • 1 to 3 years44.4%16
  • 4 to 7 years25%9
  • 8 to 11 years11.1%4
  • 12 years and over2.8%1
  • Age not given2.8%1

Weight of the animal

  • Under 5 kg (11 lb)8.3%3
  • 5 to 9.9 kg (11 to 22 lb)16.7%6
  • 10 to 24.9 kg (22 to 55 lb)36.1%13
  • 25 to 44.9 kg (55 to 99 lb)33.3%12
  • 45 kg and over (99 lb and over)0%0
  • Weight not given5.6%2

Breed, where the report gives one breed

A breed with many animals has many reports.

Route in the report

  • Oral58.3%21

Each bar is on a scale of 0 to 100%.

Approved animal drugs with these active ingredients (FDA Green Book)

This section is reference data. It has no report count.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

The Green Book lists no approved animal drug with these active ingredients. FDA also receives reports for human drugs and compounded drugs that veterinarians prescribe.

Other pages with one of these ingredients

A report names a drug by its set of active ingredients. Each set has its own page. The list is in order of name.

FDA pages for this drug

The site checked these addresses on . The links open in a new tab.

Cite this page

Pet Drug Reports. Afoxolaner + Milbemycin Oxime: adverse event reports that FDA received. https://petdrugreports.com/drug/afoxolaner-milbemycin-oxime/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .

Where the data come from

The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. The site does not use the application number that a record has.

The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.

Questions about these reports

Which brand are these reports about?

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book lists no brand name for exactly these active ingredients.

Do the reports show that the drug caused the signs?

No. FDA states this about the data.

When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.

The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

How many reports did FDA receive in the latest 12 months?

FDA received 6 reports in the 12 months to June 2026. It received 5 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

What kinds of report are in the count?

Of the 36 reports received from July 2016 to November 2025, 47.2% are about a safety issue only. 50% are about a lack of expected effectiveness, alone or with a safety issue.